Danaher Co. (NYSE:DHR) Shares Acquired by Calamos Wealth Management LLC

Calamos Wealth Management LLC increased its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 1,646.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,925 shares of the conglomerate’s stock after purchasing an additional 57,436 shares during the quarter. Danaher accounts for 0.7% of Calamos Wealth Management LLC’s holdings, making the stock its 29th largest holding. Calamos Wealth Management LLC’s holdings in Danaher were worth $13,985,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher during the 3rd quarter worth $39,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher during the third quarter worth approximately $40,000. Finally, FSA Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth approximately $50,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $214.09 on Tuesday. Danaher Co. has a twelve month low of $214.03 and a twelve month high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The business has a fifty day moving average of $235.40 and a 200-day moving average of $253.09. The firm has a market cap of $154.64 billion, a PE ratio of 40.55, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the company earned $2.09 earnings per share. On average, equities research analysts predict that Danaher Co. will post 7.77 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research report on Monday. Citigroup decreased their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, Stephens reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Read Our Latest Research Report on DHR

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 10.90% of the company’s stock.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.